The Long Run with Luke Timmerman
Ein Podcast von Timmerman Report
173 Folgen
-
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Vom: 7.6.2022 -
Ep114: Chris Gibson on Industrializing Drug Discovery
Vom: 23.5.2022 -
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
Vom: 9.5.2022 -
Ep112: Bernat Olle on Microbiome Therapeutics
Vom: 18.4.2022 -
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
Vom: 14.3.2022 -
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
Vom: 1.3.2022 -
Ep109: Derrell Porter on Cell Therapy Commercialization
Vom: 15.2.2022 -
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
Vom: 31.1.2022 -
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building
Vom: 11.1.2022 -
Ep106: Vineeta Agarwala on Health Data & VC Investing
Vom: 20.12.2021 -
Ep105: Nello Mainolfi on Targeted Protein Degraders
Vom: 6.12.2021 -
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
Vom: 1.12.2021 -
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer
Vom: 23.11.2021 -
Ep102: David Baltimore Reflects on a Life in Science
Vom: 8.11.2021 -
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs
Vom: 26.10.2021 -
Ep100: Christian Henry on Long Read DNA Sequencing
Vom: 13.10.2021 -
Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations
Vom: 27.9.2021 -
Ep98: Mara Aspinall on Diagnostics and COVID-19
Vom: 13.9.2021 -
Ep97: John Evans on Base Edited Therapeutics
Vom: 7.9.2021 -
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Vom: 9.8.2021
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
